Potential Savings of $95 Million Annually if Only Ten Percent of Central Lines Are Replaced with IO Access Success rate of 96% in establishing vascular access on first attempt; Mean time to vascular ...
FRANKLIN LAKES, N.J., Oct. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular Access ...
Intraosseous (IO) vascular access has emerged as a critical technique in emergency medicine, offering rapid and reliable delivery of fluids and medications when traditional intravenous (IV) access ...
Becton, Dickinson and Company BDX, popularly known as BD, recently launched the new BD Intraosseous (IO) Vascular Access System. The BD IO system is likely to enable access to rapid delivery of fluids ...
SAN ANTONIO--(BUSINESS WIRE)--April 18, 2006--Vidacare(R), manufacturer of the EZ-IO(R) product system, the leading solution for immediate vascular access when conventional IV access is challenging or ...
September 7, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a next-generation sternal intraosseous infusion system (FASTx; Pyng Medical Corp). The device is ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
In November the federal National Science Foundation awarded a $700,000 research grant to Hospi so that it could expand use of the only FDA-cleared device for rectal delivery of medications. The early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback